InsiderTrades.com logo

VIRX Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 10.69%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Viracta Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Viracta Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Viracta Therapeutics Share Price & Price History

Current Price: $0.01
Price Change: +0.30 (1.20%)
As of 04/8/2026 01:00 AM ET

This chart shows the closing price history over time for VIRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Viracta Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/27/2024Daniel R. ChevallardCFOSell3,405$0.73$2,485.65102,306View SEC Filing Icon  
11/30/2023Mark RotheraCEOBuy52,094$0.49$25,526.0652,094View SEC Filing Icon  
11/28/2023Daniel R. ChevallardCFOSell3,720$0.50$1,860.0098,822View SEC Filing Icon  
8/28/2023Daniel R. ChevallardCFOSell3,512$1.45$5,092.4095,653View SEC Filing Icon  
5/25/2023Daniel R. ChevallardCFOSell3,635$1.42$5,161.7092,277View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Viracta Therapeutics (NASDAQ:VIRX)

31.37% of Viracta Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VIRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Viracta Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/14/2024Stonepine Capital Management LLC500,000$0.12M0.1%N/A1.268%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC97,109$99K0.0%-42.1%0.252%Search for SEC Filing on Google Icon
8/7/2023Acadian Asset Management LLC167,818$0.24M0.0%+74.6%0.436%Search for SEC Filing on Google Icon
8/2/2023MAI Capital Management307,570$0.43M0.0%-18.9%0.800%Search for SEC Filing on Google Icon
7/20/2023Bailard Inc.47,700$67K0.0%+139.7%0.124%Search for SEC Filing on Google Icon
5/15/2023Rubric Capital Management LP1,487,385$2.37M0.1%+11.8%3.872%Search for SEC Filing on Google Icon
5/10/2023MAI Capital Management379,468$0.60M0.0%-11.1%0.988%Search for SEC Filing on Google Icon
5/8/2023Bailard Inc.19,900$32K0.0%N/A0.052%Search for SEC Filing on Google Icon
4/4/2023Trust Co. of Toledo NA OH28,000$45K0.0%N/A0.073%Search for SEC Filing on Google Icon
2/9/2023MAI Capital Management426,916$0.62M0.0%-33.0%1.118%Search for SEC Filing on Google Icon
11/14/2022Ergoteles LLC132,636$0.57M0.0%-14.7%0.353%Search for SEC Filing on Google Icon
11/14/2022Rubric Capital Management LP994,801$4.25M0.2%N/A2.649%Search for SEC Filing on Google Icon
11/8/2022Hamilton Lane Advisors LLC35,791$0.15M0.1%-49.9%0.095%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP698,000$2.71M0.0%N/A1.858%Search for SEC Filing on Google Icon
8/12/2022Ensign Peak Advisors Inc63,406$0.25M0.0%+4.8%0.169%Search for SEC Filing on Google Icon
7/20/2022Clear Harbor Asset Management LLC25,000$97K0.0%N/A0.067%Search for SEC Filing on Google Icon
7/19/2022MAI Capital Management647,950$2.51M0.0%+70.2%1.728%Search for SEC Filing on Google Icon
5/11/2022Veritable L.P.24,836$0.12M0.0%N/A0.066%Search for SEC Filing on Google Icon
5/10/2022MAI Capital Management380,788$1.81M0.0%N/A1.016%Search for SEC Filing on Google Icon
2/25/2022AlphaCentric Advisors LLC90,000$0.33M0.1%N/A0.241%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc60,515$0.22M0.0%N/A0.162%Search for SEC Filing on Google Icon
2/8/2022ProShare Advisors LLC13,174$49K0.0%N/A0.035%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp293,492$1.07M0.0%-2.8%0.787%Search for SEC Filing on Google Icon
1/28/2022Allspring Global Investments Holdings LLC73,011$0.27M0.0%N/A0.196%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Viracta Therapeutics logo
Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. Its lead product candidate is Nana-val, an all-oral combination therapy of its proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir. The company's Nana-val is in various ongoing clinical trials, including NAVAL-1, an open-label Phase 2 basket trial for the treatment of multiple subtypes of relapsed/refractory Epstein-Barr virus-positive (EBV+) lymphoma, as well as an open-label Phase 1b/2 trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors. Its product pipeline also includes vecabrutinib, a clinical-stage product candidate; and VRx-510, a preclinical product candidate. The company is headquartered in Cardiff, California.
Read More on Viracta Therapeutics

Today's Range

Now: $0.01
Low: $0.01
High: $0.01

50 Day Range

MA: $0.01
Low: $0.01
High: $0.02

52 Week Range

Now: $0.01
Low: $0.01
High: $0.56

Volume

N/A

Average Volume

1,111,440 shs

Market Capitalization

$388.70 thousand

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.06

Who are the company insiders with the largest holdings of Viracta Therapeutics?

Viracta Therapeutics' top insider investors include:
  1. Ivor Royston (CEO)
  2. Daniel R Chevallard (CFO)
  3. Mark Rothera (CEO)
  4. Lisa Rojkjaer (Insider)
Learn More about top insider investors at Viracta Therapeutics.

Viracta Therapeutics Active Insiders

Ivor Royston
Ivor Royston (Age 80)
CEO
Daniel R Chevallard
Daniel R Chevallard (Age 46)
CFO
Lisa Rojkjaer
Lisa Rojkjaer (Age 60)
Insider